4Stoli(2 R ,TrajkoviC G ,JovanoviC A ,et al. Carotid uhrasonographic pa- rameters as markers of atherogenesis and mortality rate in patients oll hemodial',sis[ J]. Vojmlsanit Pregl,2010,67( 1 1 ) :916 -922.
5Candipan RC, Wang BY, Buitrago R ,et al. Recession or progression: dependency on vascular nitric: oxide [ J ]. Arterioscler Thromb Vasc Bio1,1996,16( 1 ) :44 -50.
6Testa A, Spolo B, Sanguedolce MC,et al. eNOS and cavecdin-1 gene polymmphisnls interaction and intima media thickness:a proof of con- cepl sludy in esrd patients[ J]. Am J Hyoertens. 2011. 10:1 -6.
7Archer S. Measurement of nitric oxide in biological models[ J]. FASEB J, 1993,7 ( 2 ) :349 - 360.
8Ulrich C.Seibert E,Heine GH,el ah Monocyle angiotensin converling enzyme expression may be associated with atheroseJerosis rather than arteriosclerosis in hemodialysis patients[ J ]. Clin J Am Soc Nephrol, 2011,6(3) :505 -511.
9Ross R,Glomset JA. Athemselerosis and the arterrial smooth musele cell:Proliferation of smooth muscle is a key evbnt in the genesis of the lesions of ath en,selerosis [ J ]. Svienee, 1973,180 ( 4093 ) : 1332 - 1339.
